Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats. (Q44198491)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12406854%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

title

Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12406854%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference

pulmonary hypertension

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12406854%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

author name string

Toshihiko Nishimura

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12406854%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

John L Faul

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12406854%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Gerald J Berry

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12406854%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Daoming Qiu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12406854%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Ronald G Pearl

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12406854%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Peter N Kao

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12406854%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

language of work or name

English

0 references

publication date

15 August 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12406854%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Respiratory and Critical Care Medicine

14 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12406854%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

volume

166

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12406854%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

page(s)

1403-1408

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12406854%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12406854%20AND%20SRC:MED&resulttype=core&format=json

Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morphometric and immunohistochemical study

14 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200203-268OC

Adventitial fibroblasts: defining a role in vessel wall remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200203-268OC

Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200203-268OC

Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200203-268OC

Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200203-268OC

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200203-268OC

Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200203-268OC

40-O-(2-hydroxyethyl)-rapamycin attenuates pulmonary arterial hypertension and neointimal formation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200203-268OC

Endothelial injury and vascular reactivity in monocrotaline pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200203-268OC

Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200203-268OC

Current perspectives on statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200203-268OC

3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors block calcium-dependent tyrosine kinase Pyk2 activation by angiotensin II in vascular endothelial cells. involvement of geranylgeranylation of small G protein Rap1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200203-268OC

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200203-268OC

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200203-268OC

Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200203-268OC

Human airway epithelial cells express interleukin-2 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200203-268OC

Anti-inflammatory effects of triptolide in human bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200203-268OC

Strain differences in the response of Fischer 344 and Sprague-Dawley rats to monocrotaline induced pulmonary vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200203-268OC

The myofibroblast: an assessment of controversial issues and a definition useful in diagnosis and research

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200203-268OC

Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200203-268OC

Protein targets of monocrotaline pyrrole in pulmonary artery endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200203-268OC

Effect of pravastatin on outcomes after cardiac transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200203-268OC

Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200203-268OC

Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200203-268OC

10.1164/RCCM.200203-268OC

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12406854%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference